CD163 and atherosclerosis: Additional biomarkers, including soluble CD14 (sCD14) and soluble CD163 (sCD163), reflect monocyte and macrophage activation, respectively, and have been implicated in the pathogenesis of atherosclerosis and myocardial dysfunction.